Kikkoman Corp. is a holding company which engages in the food manufacturing business. It operates through the following segments: Domestic Foods-Manufacturing and Sales, Domestic Others, Overseas Foods-Manufacturing and Sales, and Overseas Foods-Wholesale. The Domestic Foods-Manufacturing and Sales segment manufactures and sells soy sauce, beverages, and alcoholic beverages. The Domestic Others segment involves in the production and sale of clinical diagnostic reagents, hygiene inspection agents, processing enzymes and chemical products such as hyaluronic acid. It also operates in real estate property leasing, logistics, and back-office support for Kikkoman Group, and other businesses. The Overseas Foods-Manufacturing and Sales segment sells soy sauce, Del Monte products, and overseas health foods. The Overseas Food-Wholesale segment purchases and sells oriental food products in Japan and overseas. The company was founded on December 7, 1917 and is headquartered in Noda, Japan.

Scidera Genomics LLC is an American company, with operations in Canada and the United States, that develops and commercializes biotechnology-based products to help improve animal health. It was founded by Adelene Q. Perkins and Robert A. Curtis. Scidera Genomics LLC was acquired by Neogen Corp. on January 02, 2013 for $3.40 million.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Guodian Ruiyuan (Xi'an) Intelligent Research Institute Co., Ltd., established on 2019-09-27, Business scope includes intelligent equipment research and development;cloud computing service;Augmented reality and virtual reality system development,System integration and design and construction;Building Intelligent Engineering,Construction and technology development of security engineering;Smart home product development;Research and development of optoelectronic products;Computer Hardware and Peripherals,Software Design and Development;network engineering,Design of Enterprise Information Engineering;Website Design and Development;Communication system development and integration;Automation control system development and integration,technical consulting,technology transfer,Technical Services;Daily necessities,electronic product,Electrical Equipment,Instrumentation,crafts,sales of toys.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Paradigm Therapeutics Ltd. discovers and develops drugs. The genomics-based drug discovery company uses research methods including model mouse genetics, bioinformatics and molecular biology to identify genes that serve as drug targets. The company has launched a subsidiary research center in Singapore. The company was founded in 1999 by Aparicio Samuel and Mark Carlton and is headquartered in Cambridge, UK.